These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 33976183)

  • 21. Prior dengue virus infection and risk of Zika: A pediatric cohort in Nicaragua.
    Gordon A; Gresh L; Ojeda S; Katzelnick LC; Sanchez N; Mercado JC; Chowell G; Lopez B; Elizondo D; Coloma J; Burger-Calderon R; Kuan G; Balmaseda A; Harris E
    PLoS Med; 2019 Jan; 16(1):e1002726. PubMed ID: 30668565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asynchronicity of endemic and emerging mosquito-borne disease outbreaks in the Dominican Republic.
    Petrone ME; Earnest R; Lourenço J; Kraemer MUG; Paulino-Ramirez R; Grubaugh ND; Tapia L
    Nat Commun; 2021 Jan; 12(1):151. PubMed ID: 33420058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An epidemiological survey of the current status of Zika and the immune interaction between dengue and Zika infection in Southern Taiwan.
    Wang WH; Urbina AN; Wu CC; Lin CY; Thitithanyanont A; Assavalapsakul W; Lu PL; Chen YH; Wang SF
    Int J Infect Dis; 2020 Apr; 93():151-159. PubMed ID: 31982624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shifting patterns of dengue three years after Zika virus emergence in Brazil.
    Pinotti F; Giovanetti M; de Lima MM; de Cerqueira EM; Alcantara LCJ; Gupta S; Recker M; Lourenço J
    Nat Commun; 2024 Jan; 15(1):632. PubMed ID: 38245500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral genome-based Zika virus transmission dynamics in a paediatric cohort during the 2016 Nicaragua epidemic.
    Sun H; Binder RA; Dickens B; de Sessions PF; Rabaa MA; Ho EXP; Cook AR; Carrillo FB; Monterrey JC; Kuan G; Balmaseda A; Ooi EE; Harris E; Sessions OM
    EBioMedicine; 2021 Oct; 72():103596. PubMed ID: 34627081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vector competence of Aedes aegypti from Havana, Cuba, for dengue virus type 1, chikungunya, and Zika viruses.
    Gutiérrez-Bugallo G; Boullis A; Martinez Y; Hery L; Rodríguez M; Bisset JA; Vega-Rúa A
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008941. PubMed ID: 33270652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatial evaluation and modeling of Dengue seroprevalence and vector density in Rio de Janeiro, Brazil.
    Honório NA; Nogueira RM; Codeço CT; Carvalho MS; Cruz OG; Magalhães Mde A; de Araújo JM; de Araújo ES; Gomes MQ; Pinheiro LS; da Silva Pinel C; Lourenço-de-Oliveira R
    PLoS Negl Trop Dis; 2009 Nov; 3(11):e545. PubMed ID: 19901983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in the dynamics of dengue incidence in South and Central America are possibly due to cross-population immunity after Zika virus epidemics.
    Mugabe VA; Borja LS; Cardoso CW; Weaver SC; Reis MG; Kitron U; Ribeiro GS
    Trop Med Int Health; 2021 Mar; 26(3):272-280. PubMed ID: 33190402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution and epidemiologic dynamics of dengue virus in Nicaragua during the emergence of chikungunya and Zika viruses.
    Edgerton SV; Thongsripong P; Wang C; Montaya M; Balmaseda A; Harris E; Bennett SN
    Infect Genet Evol; 2021 Aug; 92():104680. PubMed ID: 33326875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dengue Antibody and Zika: Friend or Foe?
    Durbin AP
    Trends Immunol; 2016 Oct; 37(10):635-636. PubMed ID: 27599407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-circulation and simultaneous co-infection of dengue, chikungunya, and zika viruses in patients with febrile syndrome at the Colombian-Venezuelan border.
    Carrillo-Hernández MY; Ruiz-Saenz J; Villamizar LJ; Gómez-Rangel SY; Martínez-Gutierrez M
    BMC Infect Dis; 2018 Jan; 18(1):61. PubMed ID: 29382300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey.
    Nguyen CT; Moi ML; Le TQM; Nguyen TTT; Vu TBH; Nguyen HT; Pham TTH; Le THT; Nguyen LMH; Phu Ly MH; Ng CFS; Takemura T; Morita K; Hasebe F
    BMC Infect Dis; 2020 May; 20(1):332. PubMed ID: 32393198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental Zika virus infection in
    Mourya DT; Gokhale MD; Majumdar TD; Yadav PD; Kumar V; Mavale MS
    Indian J Med Res; 2018 Jan; 147(1):88-96. PubMed ID: 29749366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A relevant in vitro human model for the study of Zika virus antibody-dependent enhancement.
    Londono-Renteria B; Troupin A; Cardenas JC; Hall A; Perez OG; Cardenas L; Hartstone-Rose A; Halstead SB; Colpitts TM
    J Gen Virol; 2017 Jul; 98(7):1702-1712. PubMed ID: 28691657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal immunity and antibodies to dengue virus promote infection and Zika virus-induced microcephaly in fetuses.
    Rathore APS; Saron WAA; Lim T; Jahan N; St John AL
    Sci Adv; 2019 Feb; 5(2):eaav3208. PubMed ID: 30820456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dengue virus 2 American-Asian genotype identified during the 2006/2007 outbreak in Piauí, Brazil reveals a Caribbean route of introduction and dissemination of dengue virus in Brazil.
    Barcelos Figueiredo L; Sakamoto T; Leomil Coelho LF; de Oliveira Rocha ES; Gomes Cota MM; Ferreira GP; de Oliveira JG; Kroon EG
    PLoS One; 2014; 9(8):e104516. PubMed ID: 25127366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of Zika and Dengue Virus Antibodies among Migrant Workers, Taiwan, 2017.
    Perng GC; Ho TC; Shih HI; Lee CH; Huang PW; Chung CH; Ko NY; Ko WC; Chien YW
    Emerg Infect Dis; 2019 Apr; 25(4):814-816. PubMed ID: 30882327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological and molecular epidemiology of the Dengue, Zika and Chikungunya viruses in a risk area in Brazil.
    Mota ML; Dos Santos Souza Marinho R; Duro RLS; Hunter J; de Menezes IRA; de Lima Silva JMF; Pereira GLT; Sabino EC; Grumach A; Diaz RS; do Socorro Lucena M; Komninakis SV
    BMC Infect Dis; 2021 Jul; 21(1):704. PubMed ID: 34303348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.